Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency
- PMID: 9372816
- DOI: 10.1016/s0741-5214(97)70091-0
Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency
Abstract
Purpose: Ultrastructural assessments of the dermal microcirculation in patients with chronic venous insufficiency have been limited to qualitative morphologic descriptions of venous ulcer edges or venous stasis dermatitis. The purpose of this investigation was to quantify differences in endothelial cell structure and local cell type with emphasis on leukocytes and their relationship to arterioles, capillaries, and postcapillary venules (PCVs).
Methods: Two 4.0 mm punch biopsies were obtained from areas of dermal stasis skin changes in the gaiter region of the leg, as well as from noninvolved areas of skin in the ipsilateral thigh, from 35 patients: CEAP class 4 (11 patients), class 5 (9 patients), class 6 (10 patients), and five normal skin biopsies from patients without chronic venous insufficiency. Electron microscopy was performed on sections at 6700x and 23,800x magnification. At 6700x endothelial cell thickness was determined, and the number of fibroblasts, leukocytes, and mast cells were recorded relative to their proximity to arterioles, capillaries, and PCVs. Similarly, at 23,800x endothelial cell vesicle density, interendothelial junctional widths, and basal lamina thickness (cuff width) were measured. Preliminary evaluation for the presence of transforming growth factor-beta 1 (TGF-beta 1) was performed on three patients using reverse transcriptase-polymerase chain reaction (RT-PCR).
Results: Quantitative measurements demonstrated increased mast cell content for class 4 and 5 patients around arterioles and PCVs and increased macrophage numbers for class 6 patients around PCVs (p < 0.05). Fibroblasts were the most common cells observed; however, no differences were demonstrated between groups. No differences were observed in interendothelial junctional widths or vesicle densities in arterioles, capillaries, or PCVs. Basal lamina thickness was increased only at the capillary level (p < 0.05). The results of RT-PCR for TGF-beta 1 messenger RNA were positive in the three patients studied.
Conclusions: Our data suggest that (1) mast cells play a role in the pathogenesis of chronic venous insufficiency; (2) the effects of mast cells, macrophages, or both may be mediated in part by TGF-beta 1; and (3) capillary cuff formation is not associated with widened interendothelial gap junctions, but may be a result of enhanced vesicular transport rate or conformational changes in the interendothelial glycocalyx.
Similar articles
-
Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta1 gene expression and protein production.J Vasc Surg. 1999 Dec;30(6):1129-45. doi: 10.1016/s0741-5214(99)70054-6. J Vasc Surg. 1999. PMID: 10587400
-
Severity of venous insufficiency is related to the density of microvascular deposition of PAI-1, uPA and von Willebrand factor.Vasa. 2004 Feb;33(1):19-24. doi: 10.1024/0301-1526.33.1.19. Vasa. 2004. PMID: 15061043
-
Microcirculatory dysfunction in chronic venous insufficiency (CVI).Microcirculation. 2000;7(6 Pt 2):S3-12. Microcirculation. 2000. PMID: 11151969 Review.
-
Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.J Vasc Surg. 2001 Nov;34(5):930-8. doi: 10.1067/mva.2001.119503. J Vasc Surg. 2001. PMID: 11700497
-
Microvascular changes in chronic venous insufficiency--a review.Cardiovasc Surg. 1995 Jun;3(3):237-45. doi: 10.1016/0967-2109(95)93871-l. Cardiovasc Surg. 1995. PMID: 7655836 Review.
Cited by
-
Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives.Physiol Rev. 2011 Jan;91(1):327-87. doi: 10.1152/physrev.00047.2009. Physiol Rev. 2011. PMID: 21248169 Free PMC article. Review.
-
Regulation of matrix contraction in chronic venous disease.Eur J Vasc Endovasc Surg. 2009 Oct;38(4):518-29. doi: 10.1016/j.ejvs.2009.05.012. Epub 2009 Jun 27. Eur J Vasc Endovasc Surg. 2009. PMID: 19560950 Free PMC article.
-
Glycocalyx disruption, endothelial dysfunction and vascular remodeling as underlying mechanisms and treatment targets of chronic venous disease.Int Angiol. 2024 Dec;43(6):563-590. doi: 10.23736/S0392-9590.24.05339-2. Int Angiol. 2024. PMID: 39873224 Review.
-
A new protocol for the treatment of the chronic venous ulcers of the lower limb.Clin Exp Med. 2012 Mar;12(1):55-60. doi: 10.1007/s10238-011-0136-7. Epub 2011 May 11. Clin Exp Med. 2012. PMID: 21559987 Clinical Trial.
-
Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs.Adv Ther. 2023 Dec;40(12):5137-5154. doi: 10.1007/s12325-023-02657-0. Epub 2023 Sep 28. Adv Ther. 2023. PMID: 37768506 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous